439 related articles for article (PubMed ID: 9759850)
1. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.
Schönbeck U; Mach F; Libby P
J Immunol; 1998 Oct; 161(7):3340-6. PubMed ID: 9759850
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
Tetlow LC; Adlam DJ; Woolley DE
Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
[TBL] [Abstract][Full Text] [Related]
3. Human IL-1 beta processing and secretion in recombinant baculovirus-infected Sf9 cells is blocked by the cowpox virus serpin crmA.
Howard AD; Palyha OC; Griffin PR; Peterson EP; Lenny AB; Ding GJ; Pickup DJ; Thornberry NA; Schmidt JA; Tocci MJ
J Immunol; 1995 Mar; 154(5):2321-32. PubMed ID: 7868902
[TBL] [Abstract][Full Text] [Related]
4. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
[TBL] [Abstract][Full Text] [Related]
5. IL-1 beta activation in human epidermis.
Nylander-Lundqvist E; Bäck O; Egelrud T
J Immunol; 1996 Aug; 157(4):1699-704. PubMed ID: 8759758
[TBL] [Abstract][Full Text] [Related]
6. Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha.
Meller D; Li DQ; Tseng SC
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2922-9. PubMed ID: 10967046
[TBL] [Abstract][Full Text] [Related]
7. Degradation of interleukin 1beta by matrix metalloproteinases.
Ito A; Mukaiyama A; Itoh Y; Nagase H; Thogersen IB; Enghild JJ; Sasaguri Y; Mori Y
J Biol Chem; 1996 Jun; 271(25):14657-60. PubMed ID: 8663297
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells.
Girard MT; Matsubara M; Fini ME
Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2441-54. PubMed ID: 1651296
[TBL] [Abstract][Full Text] [Related]
9. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke.
Anthony DC; Ferguson B; Matyzak MK; Miller KM; Esiri MM; Perry VH
Neuropathol Appl Neurobiol; 1997 Oct; 23(5):406-15. PubMed ID: 9364466
[TBL] [Abstract][Full Text] [Related]
10. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption.
Kusano K; Miyaura C; Inada M; Tamura T; Ito A; Nagase H; Kamoi K; Suda T
Endocrinology; 1998 Mar; 139(3):1338-45. PubMed ID: 9492070
[TBL] [Abstract][Full Text] [Related]
11. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
Bini A; Itoh Y; Kudryk BJ; Nagase H
Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
[TBL] [Abstract][Full Text] [Related]
12. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
13. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha.
Howard AD; Kostura MJ; Thornberry N; Ding GJ; Limjuco G; Weidner J; Salley JP; Hogquist KA; Chaplin DD; Mumford RA
J Immunol; 1991 Nov; 147(9):2964-9. PubMed ID: 1919001
[TBL] [Abstract][Full Text] [Related]
14. Induction of matrix metalloproteinase-2 and -3 activity in ovine nucleus pulposus cells grown in three-dimensional agarose gel culture by interleukin-1beta: a potential pathway of disc degeneration.
Shen B; Melrose J; Ghosh P; Taylor F
Eur Spine J; 2003 Feb; 12(1):66-75. PubMed ID: 12592549
[TBL] [Abstract][Full Text] [Related]
15. The IL-1 beta-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1 beta.
Watson RW; Rotstein OD; Parodo J; Bitar R; Marshall JC
J Immunol; 1998 Jul; 161(2):957-62. PubMed ID: 9670975
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
[TBL] [Abstract][Full Text] [Related]
17. Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 alpha and IL-1 beta occurs via a similar mechanism.
Perregaux DG; Gabel CA
J Immunol; 1998 Mar; 160(5):2469-77. PubMed ID: 9498792
[TBL] [Abstract][Full Text] [Related]
18. A major role for matrix metalloproteinases in T cell injury in the gut.
Pender SL; Tickle SP; Docherty AJ; Howie D; Wathen NC; MacDonald TT
J Immunol; 1997 Feb; 158(4):1582-90. PubMed ID: 9029093
[TBL] [Abstract][Full Text] [Related]
19. Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat.
Amantea D; Russo R; Gliozzi M; Fratto V; Berliocchi L; Bagetta G; Bernardi G; Corasaniti MT
Int Rev Neurobiol; 2007; 82():149-69. PubMed ID: 17678960
[TBL] [Abstract][Full Text] [Related]
20. Gelatinase B functions as regulator and effector in leukocyte biology.
Opdenakker G; Van den Steen PE; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
J Leukoc Biol; 2001 Jun; 69(6):851-9. PubMed ID: 11404367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
